These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 14982869

  • 21. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
    Fu JF, Liang ST, Huang YJ, Liang KH, Yen TH, Liang DC, Shih LY.
    Int J Cancer; 2017 Mar 01; 140(5):1159-1172. PubMed ID: 27859216
    [Abstract] [Full Text] [Related]

  • 22. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
    Xu D, Liu X, Yu WM, Meyerson HJ, Guo C, Gerson SL, Qu CK.
    J Exp Med; 2011 Sep 26; 208(10):1977-88. PubMed ID: 21930766
    [Abstract] [Full Text] [Related]

  • 23. Noonan syndrome and related disorders: genetics and pathogenesis.
    Tartaglia M, Gelb BD.
    Annu Rev Genomics Hum Genet; 2005 Sep 26; 6():45-68. PubMed ID: 16124853
    [Abstract] [Full Text] [Related]

  • 24. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation.
    Chantrain CF, Jijon P, De Raedt T, Vermylen C, Poirel HA, Legius E, Brichard B.
    Pediatr Blood Cancer; 2007 Jan 26; 48(1):101-4. PubMed ID: 16078230
    [Abstract] [Full Text] [Related]

  • 25. Occurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p.E139D.
    Pauli S, Steinemann D, Dittmann K, Wienands J, Shoukier M, Möschner M, Burfeind P, Manukjan G, Göhring G, Escherich G.
    Am J Med Genet A; 2012 Mar 26; 158A(3):652-8. PubMed ID: 22315187
    [Abstract] [Full Text] [Related]

  • 26. Acute lymphoblastic leukemia in the context of RASopathies.
    Cavé H, Caye A, Strullu M, Aladjidi N, Vignal C, Ferster A, Méchinaud F, Domenech C, Pierri F, Contet A, Cacheux V, Irving J, Kratz C, Clavel J, Verloes A.
    Eur J Med Genet; 2016 Mar 26; 59(3):173-8. PubMed ID: 26855057
    [Abstract] [Full Text] [Related]

  • 27. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.
    Cavé H, Caye A, Ghedira N, Capri Y, Pouvreau N, Fillot N, Trimouille A, Vignal C, Fenneteau O, Alembik Y, Alessandri JL, Blanchet P, Boute O, Bouvagnet P, David A, Dieux Coeslier A, Doray B, Dulac O, Drouin-Garraud V, Gérard M, Héron D, Isidor B, Lacombe D, Lyonnet S, Perrin L, Rio M, Roume J, Sauvion S, Toutain A, Vincent-Delorme C, Willems M, Baumann C, Verloes A.
    Eur J Hum Genet; 2016 Aug 26; 24(8):1124-31. PubMed ID: 26757980
    [Abstract] [Full Text] [Related]

  • 28. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.
    Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergsträsser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML.
    Blood; 2005 Sep 15; 106(6):2183-5. PubMed ID: 15928039
    [Abstract] [Full Text] [Related]

  • 29. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations.
    Oishi K, Gaengel K, Krishnamoorthy S, Kamiya K, Kim IK, Ying H, Weber U, Perkins LA, Tartaglia M, Mlodzik M, Pick L, Gelb BD.
    Hum Mol Genet; 2006 Feb 15; 15(4):543-53. PubMed ID: 16399795
    [Abstract] [Full Text] [Related]

  • 30. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A, Tartaglia M, Wu J, Gelb BD.
    Hum Mutat; 2004 Mar 15; 23(3):267-77. PubMed ID: 14974085
    [Abstract] [Full Text] [Related]

  • 31. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.
    Metzner A, Horstmann MA, Fehse B, Ortmeyer G, Niemeyer CM, Stocking C, Mayr GW, Jücker M.
    Gene Ther; 2007 Apr 15; 14(8):699-703. PubMed ID: 17268534
    [Abstract] [Full Text] [Related]

  • 32. Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature.
    Arrabito M, Li Volsi N, La Rosa M, Samperi P, Pulvirenti G, Cannata E, Russo G, Di Cataldo A, Lo Nigro L.
    Genes (Basel); 2024 Sep 10; 15(9):. PubMed ID: 39336782
    [Abstract] [Full Text] [Related]

  • 33. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
    Xu D, Wang S, Yu WM, Chan G, Araki T, Bunting KD, Neel BG, Qu CK.
    Blood; 2010 Nov 04; 116(18):3611-21. PubMed ID: 20651068
    [Abstract] [Full Text] [Related]

  • 34. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G, Neuer K, Ranke MB, Wittekindt NE.
    J Clin Endocrinol Metab; 2005 Sep 04; 90(9):5377-81. PubMed ID: 15985475
    [Abstract] [Full Text] [Related]

  • 35. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP.
    Nat Genet; 2006 Mar 04; 38(3):331-6. PubMed ID: 16474405
    [Abstract] [Full Text] [Related]

  • 36. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS.
    Nat Genet; 2007 Jan 04; 39(1):70-4. PubMed ID: 17143285
    [Abstract] [Full Text] [Related]

  • 37. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M, Matheson E, Minto L, Hassan R, Harrison CJ, Bown N, Bailey S, Vormoor J, Hall AG, Irving JA.
    Cancer Res; 2008 Aug 15; 68(16):6803-9. PubMed ID: 18701506
    [Abstract] [Full Text] [Related]

  • 38. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation.
    Sakamoto K, Imamura T, Asai D, Goto-Kawashima S, Yoshida H, Fujiki A, Furutani A, Ishida H, Aoki Y, Hosoi H.
    J Pediatr Hematol Oncol; 2014 Mar 15; 36(2):e136-9. PubMed ID: 24072241
    [Abstract] [Full Text] [Related]

  • 39. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling.
    Uhlén P, Burch PM, Zito CI, Estrada M, Ehrlich BE, Bennett AM.
    Proc Natl Acad Sci U S A; 2006 Feb 14; 103(7):2160-5. PubMed ID: 16461457
    [Abstract] [Full Text] [Related]

  • 40. The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.
    Alfayez M, Issa GC, Patel KP, Wang F, Wang X, Short NJ, Cortes JE, Kadia T, Ravandi F, Pierce S, Assi R, Garcia-Manero G, DiNardo CD, Daver N, Pemmaraju N, Kantarjian H, Borthakur G.
    Leukemia; 2021 Mar 14; 35(3):691-700. PubMed ID: 32561839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.